Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
29,897
datasets available to search
ShareScore release 0.9.0
Dataset results
29,897 results for “activism”
Reducing Hopelessness Through Improved Physical Activity in Adults With Heart Disease: With COVID-19 Considerations
ClinicalTrials.gov study NCT03907891. IPD Sharing: YES. Countries: 1. Publications: 5.
Molecular Transducers of Physical Activity Consortium (MoTrPAC) - Pediatric Protocol
ClinicalTrials.gov study NCT04151199. IPD Sharing: YES. Countries: 1. Publications: 1.
Developing and Testing the Enhancing Active Caregiver Training (EnACT) Intervention for Dementia Family Caregivers
ClinicalTrials.gov study NCT04920006. IPD Sharing: YES. Countries: 1. Publications: 5.
Behavioral Activation for PTSD/Depression Treatment in OIF/OEF Veterans
ClinicalTrials.gov study NCT00805532. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
ClinicalTrials.gov study NCT02819635. IPD Sharing: YES. Countries: 46. Publications: 13.
24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis
ClinicalTrials.gov study NCT01989468. IPD Sharing: UNDECIDED. Countries: 13. Publications: 5.
Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease
ClinicalTrials.gov study NCT03491215. IPD Sharing: YES. Countries: 8. Publications: 1.
Open-label Extension Study of Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Lupus Nephritis
ClinicalTrials.gov study NCT05232864. IPD Sharing: YES. Countries: 13. Publications: 1.
Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients
ClinicalTrials.gov study NCT03744910. IPD Sharing: YES. Countries: 15. Publications: 4.
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheum
ClinicalTrials.gov study NCT03675308. IPD Sharing: YES. Countries: 39. Publications: 9.
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis
ClinicalTrials.gov study NCT02294227. IPD Sharing: UNDECIDED. Countries: 13. Publications: 3.
Active You: A Novel Exercise Program for African Americans
ClinicalTrials.gov study NCT04280783. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis
ClinicalTrials.gov study NCT04181762. IPD Sharing: YES. Countries: 34. Publications: 2.
Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT03774082. IPD Sharing: YES. Countries: 14. Publications: 1.
16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis
ClinicalTrials.gov study NCT01649375. IPD Sharing: UNDECIDED. Countries: 13. Publications: 14.
User-Led Meaningful Activity and Early-Stage Dementia
ClinicalTrials.gov study NCT05159869. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Preventing Posttraumatic Osteoarthritis With Physical Activity Promotion
ClinicalTrials.gov study NCT04906499. IPD Sharing: YES. Countries: 1. Publications: 26.
Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement
ClinicalTrials.gov study NCT02721966. IPD Sharing: UNDECIDED. Countries: 18. Publications: 2.
Safety and Immunotherapeutic Activity of an Anti-PD-1 Antibody (Cemiplimab) in Participants With HIV-1 on Suppressive cART
ClinicalTrials.gov study NCT03787095. IPD Sharing: YES. Countries: 1. Publications: 2.
Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy
ClinicalTrials.gov study NCT03344640. IPD Sharing: UNDECIDED. Countries: 5. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.